Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2007-05-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.297.17.1892PMID 17473299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of heparins in Non-ST-elevation acute coronary syndromes.

  2007cited by this paper
• FOCUS ISSUE: CARDIAC INTERVENTION Intervention in Acute Coronary Syndromes Benefit of Early Invasive Therapy in Acute Coronary Syndromes A Meta-Analysis of Contemporary Randomized Clinical Trials

  2006cited by this paper
• Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.

  2005cited by this paper
• Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.

  2005cited by this paper
• Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE)

  2005cited by this paper
• 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.

  2005cited by this paper
• Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction.

  2005cited by this paper
• ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi

  2004cited by this paper
• A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study).

  2004cited by this paper
• From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE).

  2003cited by this paper
• Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

  2003cited by this paper
• Predictors of hospital mortality in the global registry of acute coronary events.

  2003cited by this paper
• Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE).

  2002cited by this paper
• Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

  2002cited by this paper
• Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE).

  2002cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients

  2002cited by this paper
• Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

  2002cited by this paper
• Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes.

  2001cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial.

  2001cited by this paper
• Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

  2000cited by this paper
• Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

  2000cited by this paper
• Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3.

  2000cited by this paper
• Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study

  1999cited by this paper
• Long-term low-molecular-mass heparin in unstable coronary-artery disease : FRISC II prospective randomised multicentre study.

  1999cited by this paper
• Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.

  1999cited by this paper
• Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators.

  1999cited by this paper
• Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strate

  1998cited by this paper
• Invasive versus conservative strategies in unstable angina and non\NQ-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 trial ☆

  1998cited by this paper
• A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.

  1996cited by this paper
• ORIGINAL CONTRIBUTION Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes

  year unknowncited by this paper

• Development and validation of diagnostic and prognostic models for heart failure in unstable angina patients

  2026cites this paper
• Reperfusion therapy for older patients with acute myocardial infarction and cardiogenic shock.

  2026cites this paper
• Fluid balance trajectories and prognosis in patients with acute myocardial infarction complicated by cardiogenic shock: a group-based trajectory model approach

  2026cites this paper
• Intracoronary Infusion of Supersaturated Oxygen in Patients With Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

  2025cites this paper
• Plasma expression of lncRNA Wisper in patients with heart failure and patients with myocardial infarction

  2025cites this paper
• Effectiveness of a Simplified Checklist to Overcome the Inertia of Treatment Implementation in ACS Patients with High Comorbidity Burden

  2025cites this paper
• The association between short-term exposure to ambient PM2.5 and hospitalization costs in patients with myocardial infarction: a hospital-based study

  2025cites this paper
• miRNome profile in blood samples upstream and downstream of the coronary lesion and arterial aortic root before and after angioplasty in subjects with chronic and acute coronary syndrome: A pilot observational study protocol (Plaque study)

  2025cites this paper
• The current use of vasoactive agents in cardiogenic shock related to myocardial infarction and acute decompensated heart failure

  2025cites this paper
• Observational analysis of non-ST-segment elevation myocardial infarction invasive management and mortality over the decades

  2025cites this paper
• Evaluation of the Relationship Between Laboratory Parameters, Severity of Coronary Artery Disease, and Adverse Clinical Outcomes in Patients Undergoing Coronary Angiography

  2025cites this paper
• Emerging therapy strategies for energy metabolism in acute myocardial infarction

  2025cites this paper
• Comparison of Clinical Outcomes in Patients With Acute Myocardial Infarction Between Those With and Without Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

  2025cites this paper
• Exploring the Latest Advances in Tenecteplase in the Treatment of Acute ST-Segment Elevation Myocardial Infarction

  2025cites this paper
• Prevention of heart failure after acute myocardial infarction.

  2025cites this paper
• Influence of Hospital Ownership on Patient Outcomes in ST-Elevation Myocardial Infarction-Induced Cardiogenic Shock Undergoing Revascularization: A Retrospective Cohort Study

  2025cites this paper
• Molecular signatures bidirectionally link myocardial infarction and lung cancer

  2025cites this paper
• Factors associated with reduced left ventricular ejection fraction in patients with primary myocardial infarction

  2025cites this paper
• Prognostic value of E/e' ratio and its change over time in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction in the reperfusion era.

  2024cites this paper
• Shock Simulation Day: Medical Decision-Making and Communication Skills for Managing a Hypotensive Adult in a Rapid Response

  2024cites this paper
• Prevalence and prognosis of aortic valve diseases in patients hospitalized with heart failure with mildly reduced ejection fraction

  2024cites this paper
• Impact of the Integrated Activation System on Door-to-Balloon Times and Clinical Outcomes in STEMI Patients Receiving Primary PCI.

  2024cites this paper
• Vitamin C as Scavenger of Reactive Oxygen Species during Healing after Myocardial Infarction

  2024cites this paper
• Early initiation of oral beta-blocker improves long-term survival in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention

  2024cites this paper
• A combination of left ventricular outflow tract velocity time integral and lung ultrasound to predict mortality in ST elevation myocardial infarction

  2024cites this paper
• Statins as anti‐tumor agents: A paradigm for repurposed drugs

  2024cites this paper
• Machine learning-based prediction of mortality in acute myocardial infarction with cardiogenic shock

  2024cites this paper
• Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting

  2024cites this paper
• Temporal trends of in-hospital mortality and its determinants following percutaneous coronary intervention in patients with acute coronary syndrome in England and Wales: A population-based study between 2006 and 2021.

  2024cites this paper
• Clinical predictors of coronary artery bypass graft surgery in patients hospitalized for Non-ST acute coronary syndrome - Buenos Aires I and ReSCAR22 registries

  2024cites this paper
• Gender Disparities on the Use and Outcomes of Mechanical Circulatory Support in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction.

  2024cites this paper
• Distribution and prognostic impact of different heart failure etiologies in patients with heart failure with mildly reduced ejection fraction: Etiology in heart failure with mildly reduced ejection fraction.

  2024cites this paper
• Management of Myocardial Infarction: Emerging Paradigms for the Future

  2024cites this paper
• Three-year outcomes following non-ST-segment elevation myocardial infarction and new-generation drug-eluting stent implantation, stratified by patient age (under and over 75 years) and left ventricular ejection fraction: A prospective cohort study

  2024cites this paper
• Tendances temporelles et impact pronostique des modalités de reperfusion chez les patients Tunisiens se présentant pour infarctus avec sus décalage du segment ST : Analyse sur 20 ans

  2023cites this paper
• Contemporary Trends in Clinical Characteristics, Therapeutic Strategies and Outcomes in Patients Aged 80 Years and Older Presenting with non-ST Elevation Myocardial Infarctions in the United States.

  2023cites this paper
• Effect of Ivabradine in Controlling Heart Rate in Patients with Sepsis and Septic Shock: Randomized Control Trails

  2023cites this paper
• Clinical determinants of ischemic heart disease in Eastern Europe

  2023cites this paper
• The global prevalence of myocardial infarction: a systematic review and meta-analysis

  2023cites this paper
• The prothrombin time/international normalized ratio predicts prognosis in cardiogenic shock

  2023cites this paper
• Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction Complicated by Cardiogenic Shock in a Super-aging Society.

  2023cites this paper
• Outcomes of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Non-ST-Elevation Myocardial Infarction-Propensity Matched Regression Analysis.

  2023cites this paper
• Quality of Coronary Care: Reducing Practice Variability.

  2023cites this paper
• Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarction

  2023cites this paper
• Twenty Years of an Institutional Chest Pain Pathway: What’s Come and What’s Yet to Come

  2023cites this paper
• Use of the Pharmacoinvasive Strategy in Argentina. ARGEN-IAM ST Registry Analysis

  2023cites this paper
• Incidence of Mid-Term Prognostic Events in Patients With Acute Coronary Syndrome During the Late 2010s in 2 Tertiary Hospitals in a Rural Area of Japan　― A Temporal Comparison ―

  2023cites this paper
• Radiomics-based machine learning models in STEMI: a promising tool for the prediction of major adverse cardiac events

  2023influential citation
• Perspectives and Considerations of IABP in the Era of ECMO for Cardiogenic Shock.

  2023cites this paper
• A Study on Prediction of Myocardial Infarction Using Computational Intelligence and Machine Learning Algorithms

  2023cites this paper
• Assessment of Hospital Performance Using Quality of Care Indicators in Patients with Acute Coronary Syndrome

  2022influential citation
• PREDICTING MYOCARDIAL INFARCTION COMPLICATIONS AND OUTCOMES WITH DEEP LEARNING

  2022cites this paper
• Performance of the ATRIA Bleeding Score in Predicting the Risk of In-Hospital Bleeding in Patients with ST-Elevation or Non-ST-Elevation Myocardial Infarction

  2022cites this paper
• Outcomes of early versus delayed invasive strategy in older adults with non-ST-segment elevation myocardial infarction

  2022cites this paper
• Geographical inequalities in the decreasing 28-day mortality following incident acute myocardial infarction: a Danish register-based cohort study, 1987–2016

  2022cites this paper
• Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock

  2022cites this paper
• Echocardiographic Characteristics of Cardiogenic Shock in the Cardiology Department of the Yalgado OUEDRAOGO University Hospital of Ouagadougou

  2022cites this paper
• Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis

  2022cites this paper
• Encuesta Nacional de infarto agudo de miocardio con elevación del ST en la República Argentina (ARGENT-IAM-ST)

  2022cites this paper
• Prognostic value of D-dimer to fibrinogen ratio for patients with acute myocardial infarction

  2022cites this paper
• Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era

  2022cites this paper
• Predictors of Left Ventricular Dysfunction after Percutaneous Primary Coronary Intervention in Acute Anterior Myocardial Infarction

  2022cites this paper
• Association of beta-blocker therapy at discharge with clinical outcomes in patients without heart failure or left ventricular systolic dysfunction after acute coronary syndrome: An updated systematic review and meta-analysis.

  2022cites this paper
• Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany

  2022cites this paper
• Comparison of 3-Year Outcomes between Early and Delayed Invasive Strategies in Older and Younger Adults with Non-ST-Segment Elevation Myocardial Infarction Undergoing New-Generation Drug-Eluting Stent Implantation

  2022influential citation
• Trends in treatment and outcomes of patients with diabetes and acute myocardial infarction: Insights from the nationwide AMIS plus registry.

  2022cites this paper
• A Novel Biomarker Scoring System Alone or in Combination with the GRACE Score for the Prognostic Assessment in Non-ST-Elevation Myocardial Infarction

  2022cites this paper
• Long-term mortality after ST-elevation myocardial infarction in the reperfusion and modern secondary prevention therapy era according to coronary artery disease extent: The FAST-MI registries.

  2021cites this paper
• Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction

  2021cites this paper
• Haemoglobin drop with and without bleeding in patients with acute coronary syndromes

  2021cites this paper
• Performance of the GRACE 2.0 and EPICOR risk scores for predicting 1-year postdischarge mortality in Vietnamese patients with acute coronary syndrome

  2021cites this paper
• Levosimendan in Cardiogenic Shock and Low Cardiac Output Syndrome

  2021cites this paper
• Associations of Lipoprotein(a) With Coronary Atherosclerotic Burden and All-Cause Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

  2021cites this paper
• Using Restricted Cubic Splines to Study the Trajectory of Systolic Blood Pressure in the Prognosis of Acute Myocardial Infarction

  2021cites this paper
• Reduction of door‐to‐balloon time in patients with ST‐elevation myocardial infarction by single‐catheter primary percutaneous coronary intervention method

  2021cites this paper
• Atherosclerosis: Cholesterol Management

  2021influential citation
• Assessment of Hospital Performance Using Quality of Care Indicators in Patients with Acute ST Elevation Myocardial Infarction in an Egyptian University Hospital

  2021cites this paper
• Assessment of the Clinical and Procedural Predictive Factors of No-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention

  2021cites this paper
• Five-year risk of heart failure and death following myocardial infarction with cardiogenic shock: a nationwide cohort study.

  2021cites this paper
• Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort study

  2021cites this paper
• Management of ST-Elevation Myocardial Infarction in High-Risk Settings

  2021cites this paper
• Is coronary multivessel disease in acute myocardial infarction patients still associated with worse clinical outcomes at 1‐year?

  2021cites this paper
• Demographics, practice patterns and long-term outcomes of patients with non–ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3

  2021cites this paper
• Coronary Artery Disease in the Arab World

  2021cites this paper
• Prognostic value of free triiodothyronine and N-terminal pro-B-type natriuretic peptide for patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study

  2021cites this paper
• EMERGING STRATEGIES IN ANTI THROMBOTIC THERAPY WITH STABLE VESICULAR DISEASES – CURRENT STATE OF ART

  2021cites this paper
• The mortality rates in registries of patients with STEMI are highly affected by inclusion criteria and population characteristics

  2021cites this paper
• Cardiogenic Shock After Acute Myocardial Infarction: A Review.

  2021cites this paper
• Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial.

  2021cites this paper
• No-Reflow nas Síndromes Coronarianas Agudas: Um Velho Inimigo ou uma Nova Fronteira?

  2021cites this paper
• Identifying cardiogenic shock in the emergency department.

  2020influential citation
• Effect of Gender on the Outcomes of ST-Elevation Myocardial Infarction at a Tertiary Care Hospital in Riyadh, Saudi Arabia

  2020cites this paper
• Association of Computer-Assisted Virtual Preoperative Planning With Postoperative Mortality and Complications in Older Patients With Intertrochanteric Hip Fracture

  2020cites this paper
• Investigation of anemia risk factors and its related outcomes in patients with ST-elevation myocardial infarction

  2020cites this paper
• MRI for measuring therapy efficiency after revascularisation in ST-segment elevation myocardial infarction: a systematic review and meta-regression analysis

  2020cites this paper
• Basic Fibroblast Growth Factor Attenuates Injury in Myocardial Infarction by Enhancing Hypoxia-Inducible Factor-1 Alpha Accumulation

  2020cites this paper
• Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy.

  2020cites this paper
• Acute kidney injury in cardiogenic shock: A comprehensive review

  2020cites this paper
• Bedside insertion of impella percutaneous ventricular assist device in patients with cardiogenic shock.

  2020cites this paper
• Identifying the most important ECG predictors of reduced ejection fraction in patients with suspected acute coronary syndrome.

  2020cites this paper